Largest real-world cohort confirms PSMA radiopharmaceutical therapy works in routine prostate cancer care
A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that 177Lu-PSMA-617 produced efficacy and safety outcomes ...
